Kura Oncology's ziftomenib shows promise in AML treatment, with key data readouts expected in 2025, but faces competition from Syndax's revumenib. Kura's strong cash position supports operations ...

Lake Street analyst Mark Smith upgraded Kura Sushi (KRUS) to Buy from Hold with a $103 price target See what stocks are receiving strong buy ratings from top-rated analysts. Filter, analyze ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The road agency further urged motorists will be required to use alternative routes and to follow guidelines issued by the traffic police. The renovations come after complaints by Syokimau ...

After hours: March 11 at 7:54:48 PM EDT Loading Chart for KRUS ...

After hours: March 7 at 6:39:55 PM EST ...